Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002118:Calcium / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004533:Egtazic Acid / Q000494:pharmacology; D011464:Epoprostenol / Q000494:pharmacology; D005707:Gallic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D008954:Models, Biological; D010974:Platelet Aggregation / Q000187:drug effects; D011463:Prostaglandins H / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013928:Thromboxane A2 / Q000494:pharmacology*; D013929:Thromboxane B2 / Q000096:biosynthesis; D013931:Thromboxanes / Q000494:pharmacology*
D011463:Prostaglandins H; D013931:Thromboxanes; D012701:Serotonin; D004533:Egtazic Acid; D013929:Thromboxane B2; D013928:Thromboxane A2; D000244:Adenosine Diphosphate; D005707:Gallic Acid; D011464:Epoprostenol; D000242:Cyclic AMP; D002118:Calcium